Literature DB >> 34528792

Enzymatically Forming Intranuclear Peptide Assemblies for Selectively Killing Human Induced Pluripotent Stem Cells.

Shuang Liu1,2, Qiuxin Zhang1, Adrianna N Shy1, Meihui Yi1, Hongjian He1, Shijiang Lu3, Bing Xu1.   

Abstract

Tumorigenic risk of undifferentiated human induced pluripotent stem cells (iPSCs), being a major obstacle for clinical application of iPSCs, requires novel approaches for selectively eliminating undifferentiated iPSCs. Here, we show that an l-phosphopentapeptide, upon the dephosphorylation catalyzed by alkaline phosphatase (ALP) overexpressed by iPSCs, rapidly forms intranuclear peptide assemblies made of α-helices to selectively kill iPSCs. The phosphopentapeptide, consisting of four l-leucine residues and a C-terminal l-phosphotyrosine, self-assembles to form micelles/nanoparticles, which transform into peptide nanofibers/nanoribbons after enzymatic dephosphorylation removes the phosphate group from the l-phosphotyrosine. The concentration of ALP and incubation time dictates the morphology of the peptide assemblies. Circular dichroism and FTIR indicate that the l-pentapeptide in the assemblies contains a mixture of an α-helix and aggregated strands. Incubating the l-phosphopentapeptide with human iPSCs results in rapid killing of the iPSCs (=<2 h) due to the significant accumulation of the peptide assemblies in the nuclei of iPSCs. The phosphopentapeptide is innocuous to normal cells (e.g., HEK293 and hematopoietic progenitor cell (HPC)) because normal cells hardly overexpress ALP. Inhibiting ALP, mutating the l-phosphotyrosine from the C-terminal to the middle of the phosphopentapeptides, or replacing l-leucine to d-leucine in the phosphopentapeptide abolishes the intranuclear assemblies of the pentapeptides. Treating the l-phosphopentapeptide with cell lysate of normal cells (e.g., HS-5) confirms the proteolysis of the l-pentapeptide. This work, as the first case of intranuclear assemblies of peptides, not only illustrates the application of enzymatic noncovalent synthesis for selectively targeting nuclei of cells but also may lead to a new way to eliminate other pathological cells that express a high level of certain enzymes.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34528792      PMCID: PMC8588069          DOI: 10.1021/jacs.1c07923

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   16.383


  77 in total

1.  The 225-240-nm circular dichroism band in disordered and charged polypeptides.

Authors:  W B Rippon; W A Hiltner
Journal:  Macromolecules       Date:  1973 Mar-Apr       Impact factor: 5.985

2.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

3.  Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.

Authors:  Aeyung Kim; Seo-Young Lee; Chang-Seob Seo; Sun-Ku Chung
Journal:  Phytomedicine       Date:  2020-02-26       Impact factor: 5.340

4.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

5.  Selective ablation of human embryonic stem cells expressing a "suicide" gene.

Authors:  Maya Schuldiner; Joseph Itskovitz-Eldor; Nissim Benvenisty
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

6.  Selective eradication of pluripotent stem cells by inhibiting DHODH activity.

Authors:  Toru Kondo
Journal:  Stem Cells       Date:  2020-10-12       Impact factor: 6.277

Review 7.  Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products.

Authors:  Shin Kawamata; Hoshimi Kanemura; Noriko Sakai; Masayo Takahashi; Masahiro J Go
Journal:  J Clin Med       Date:  2015-01-14       Impact factor: 4.241

8.  Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine.

Authors:  Takunori Nagashima; Kazunori Shimizu; Ryo Matsumoto; Hiroyuki Honda
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

Review 9.  Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine.

Authors:  Paul S Knoepfler
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

10.  Imaging enzyme-triggered self-assembly of small molecules inside live cells.

Authors:  Yuan Gao; Junfeng Shi; Dan Yuan; Bing Xu
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more
  8 in total

Review 1.  Enzymatic noncovalent synthesis of peptide assemblies generates multimolecular crowding in cells for biomedical applications.

Authors:  Meihui Yi; Weiyi Tan; Jiaqi Guo; Bing Xu
Journal:  Chem Commun (Camb)       Date:  2021-12-03       Impact factor: 6.222

2.  Highly sensitive and non-disruptive detection of residual undifferentiated cells by measuring miRNAs in culture supernatant.

Authors:  Kanako Masumoto; Yuki Aihara; Mao Miyagawa Kuroishi; Natsuki Maeda; Yumiko Sakai; Yuma Oka; Yusuke Takahashi; Kenta Oda; Masatoshi Yanagida
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

Review 3.  Enzymatic Noncovalent Synthesis for Targeting Subcellular Organelles.

Authors:  Qiuxin Zhang; Weiyi Tan; Bing Xu
Journal:  Chempluschem       Date:  2022-03-24       Impact factor: 3.210

Review 4.  Supramolecular Nanomedicines of In-Situ Self-Assembling Peptides.

Authors:  Ying Zhang; Yingying Yu; Jie Gao
Journal:  Front Chem       Date:  2022-02-04       Impact factor: 5.221

5.  Synthesis and bioactivity of pyrrole-conjugated phosphopeptides.

Authors:  Qiuxin Zhang; Weiyi Tan; Bing Xu
Journal:  Beilstein J Org Chem       Date:  2022-01-31       Impact factor: 2.883

6.  PDGF-BB-derived supramolecular hydrogel for promoting skin wound healing.

Authors:  Ke Jian; Chenghao Yang; Tingting Li; Xia Wu; Jun Shen; Jiaying Wei; Zhimou Yang; Dan Yuan; Mingyi Zhao; Junfeng Shi
Journal:  J Nanobiotechnology       Date:  2022-04-26       Impact factor: 9.429

Review 7.  Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes.

Authors:  Silvia Pellegrini; Valentina Zamarian; Valeria Sordi
Journal:  Transpl Int       Date:  2022-08-24       Impact factor: 3.842

Review 8.  Peptide-Based Low Molecular Weight Photosensitive Supramolecular Gelators.

Authors:  Bapan Pramanik; Sahnawaz Ahmed
Journal:  Gels       Date:  2022-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.